PsychoactiveMap

MDMA clinical trials in the registry

Data as of 31 October 2026. Source: ClinicalTrials.gov records held by PsychoactiveMap, refreshed from a reviewed snapshot.

MDMA (3,4-methylenedioxymethamphetamine) is a synthetic compound that registered studies often pair with structured psychological support. This page summarises registered studies whose registry records mention MDMA, using PsychoactiveMap's copy of the ClinicalTrials.gov registry.

Educational information, not medical advice. A registry listing is not evidence of safety, benefit or results, and it is not a recommendation. PsychoactiveMap does not recruit, screen or refer participants. Status and other details are copied from the registry and can be out of date, so check the registry record and speak to a qualified health professional before any decision. Read the full disclaimer.

At a glance

By registry status

StatusStudiesShare
Recruiting2320%
Not yet recruiting54%
Enrolling by invitation33%
Active, not recruiting33%
Completed6557%
Terminated43%
Withdrawn65%
Status not reported65%

By phase

PhaseStudiesShare
Early Phase 1109%
Phase 13631%
Phase 24337%
Phase 376%
Not applicable1110%
Not reported87%

Countries

Country is taken from the study's linked research site. 6 of 115 records have no country on file. The top 10 countries are shown.

CountryStudiesShare
United States6355%
Switzerland2723%
Israel109%
Canada76%
Spain33%
Netherlands33%
United Kingdom22%
Australia11%
Czechia11%
Germany11%

Registry-listed start years

Start yearStudies
2024 and later38
2020 to 202332
2015 to 201912
2010 to 201420
Before 201012
Start date not reported1

Study design

Topics named in study titles

A keyword match on registered titles, so one study can appear under more than one topic and a study can be missed. It describes what titles mention, nothing more.

TopicStudies
Trauma and PTSD48
Other substance use20
Healthy volunteers12
Anxiety4
Alcohol use3
Cancer and end of life2
Pain and headache1
Eating disorders1

Latest registry-listed start dates

The 25 studies with the latest start dates, shown newest first. Dates may be estimated, including future dates; a listed date does not confirm that a study started. The order is not a ranking and says nothing about quality. Each ID links to its own ClinicalTrials.gov record, which has the eligibility criteria and contacts.

Registry IDTitle as registeredStatusPhaseCountryRegistry dates
NCT07765693MDMA-AT for PTSD in Young Adults With Childhood TraumaNot yet recruitingPhase 2United StatesSource start: 2026-10-31 (estimated)
Source date details

Start: 2026-10-31 (precision: day; source type: ESTIMATED; estimated)

Primary completion: 2028-01-30 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2028-12-01 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-08-20 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07704762Clinical Trial of MDMA-Assisted Therapy for Military Service Members With Posttraumatic Stress DisorderNot yet recruitingPhase 2Not reportedSource start: 2026-10-01 (estimated)
Source date details

Start: 2026-10-01 (precision: day; source type: ESTIMATED; estimated)

Primary completion: 2028-01-01 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2028-10-01 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-07-15 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07555132Circulating Oxytocin Changes in Response to MDMA vs. Placebo in Adult Patients With Autism Spectrum Disorder and Matched Healthy ControlsNot yet recruitingNot applicableSwitzerlandSource start: 2026-06 (estimated)
Saved start 2026-06-01 differs from reported 2026-06; the saved day is not established by this observation.
Source date details

Start: 2026-06 (precision: month; source type: ESTIMATED; estimated)

Primary completion: 2028-06 (precision: month; source type: ESTIMATED; estimated)

Study completion: 2028-06 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.566Z; registry revision: 2026-04-29 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07542145MDMA Assisted Therapy for BNRecruitingPhase 1United StatesSource start: 2026-05-22 (actual)
Saved start 2026-05-01 differs from reported 2026-05-22; the saved day is not established by this observation.
Source date details

Start: 2026-05-22 (precision: day; source type: ACTUAL; actual)

Primary completion: 2028-04-30 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2028-04-30 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.566Z; registry revision: 2026-06-22 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07569159MDMA Therapy in Veterans With PTSDRecruitingPhase 2United StatesSource start: 2026-06-30 (estimated)
Saved start 2026-05-01 differs from reported 2026-06-30; the saved day is not established by this observation.
Source date details

Start: 2026-06-30 (precision: day; source type: ESTIMATED; estimated)

Primary completion: 2027-04-01 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2027-08 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.566Z; registry revision: 2026-07-01 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07584720Study of Midomafetamine in Healthy AdultsActive, not recruitingPhase 1United StatesSource start: 2026-04-23 (actual)
Source date details

Start: 2026-04-23 (precision: day; source type: ACTUAL; actual)

Primary completion: 2026-07-23 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2027-02-28 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.566Z; registry revision: 2026-06-29 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07118839MDMA-Assisted Therapy for Veterans With PTSD and Alcohol Use DisorderRecruitingPhase 2United StatesSource start: 2026-05-18 (actual)
Saved start 2026-04-15 differs from reported 2026-05-18; the saved day is not established by this observation.
Source date details

Start: 2026-05-18 (precision: day; source type: ACTUAL; actual)

Primary completion: 2030-05-01 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2030-05-30 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.160Z; registry revision: 2026-06-02 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT05455996MDMA-Assisted Therapy for Stress Disorders in Healthcare WorkersNot yet recruitingPhase 2United StatesSource start: 2026-10 (estimated)
Saved start 2026-04-01 differs from reported 2026-10; the saved day is not established by this observation.
Source date details

Start: 2026-10 (precision: month; source type: ESTIMATED; estimated)

Primary completion: 2028-01 (precision: month; source type: ESTIMATED; estimated)

Study completion: 2028-06 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:16.239Z; registry revision: 2026-05-05 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT06066853MDMA-assisted Therapy for FibromyalgiaRecruitingEarly Phase 1United StatesSource start: 2026-09-15 (estimated)
Saved start 2026-04-01 differs from reported 2026-09-15; the saved day is not established by this observation.
Source date details

Start: 2026-09-15 (precision: day; source type: ESTIMATED; estimated)

Primary completion: 2026-12 (precision: month; source type: ESTIMATED; estimated)

Study completion: 2026-12 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:17.019Z; registry revision: 2026-08-26 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT03606538MDMA in Subjects With Moderate Hepatic Impairment and Subjects With Normal Hepatic FunctionNot yet recruitingPhase 1United StatesSource start: 2026-03-29 (estimated)
Source date details

Start: 2026-03-29 (precision: day; source type: ESTIMATED; estimated)

Primary completion: 2028-12 (precision: month; source type: ESTIMATED; estimated)

Study completion: 2028-12 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:14.715Z; registry revision: 2024-10-30 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07494214Acute Analgesic Effects of MDMA on Experimentally Induced Acute Pain, Hyperalgesia and Allodynia in Healthy ParticipantsRecruitingPhase 1SwitzerlandSource start: 2026-03-09 (actual)
Source date details

Start: 2026-03-09 (precision: day; source type: ACTUAL; actual)

Primary completion: 2027-03-09 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2027-04-09 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.566Z; registry revision: 2026-03-27 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT04454684A Multi-Site Study of MDMA-Assisted Psychotherapy for Eating DisordersWithdrawnPhase 2Not reportedSource start: 2026-02 (estimated)
Saved start 2026-02-01 differs from reported 2026-02; the saved day is not established by this observation.
Source date details

Start: 2026-02 (precision: month; source type: ESTIMATED; estimated)

Primary completion: 2028-08-10 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2028-08-10 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:15.458Z; registry revision: 2024-10-31 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07102576MDMA-Assisted Therapy for Mental Healthcare ProvidersRecruitingPhase 1United StatesSource start: 2026-02-11 (actual)
Saved start 2026-01-01 differs from reported 2026-02-11; the saved day is not established by this observation.
Source date details

Start: 2026-02-11 (precision: day; source type: ACTUAL; actual)

Primary completion: 2029-09-21 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2029-12-21 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.089Z; registry revision: 2026-03-27 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07288151MDMA-Assisted Massed Exposure Therapy for PTSDRecruitingPhase 2United StatesSource start: 2026-07 (estimated)
Saved start 2026-01-01 differs from reported 2026-07; the saved day is not established by this observation.
Source date details

Start: 2026-07 (precision: month; source type: ESTIMATED; estimated)

Primary completion: 2030-01 (precision: month; source type: ESTIMATED; estimated)

Study completion: 2030-01 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.483Z; registry revision: 2026-05-26 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07469098Group vs Individual MDMA-Assisted Therapy for PTSD After the October 7, 2023 EventsRecruitingPhase 2IsraelSource start: 2025-12-24 (actual)
Source date details

Start: 2025-12-24 (precision: day; source type: ACTUAL; actual)

Primary completion: 2028-12-31 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2029-03-31 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:12.355Z; registry revision: 2026-03-13 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07303907A Phase 2A Trial of DT402 for Autism Spectrum DisorderRecruitingPhase 2United StatesSource start: 2025-12-03 (actual)
Source date details

Start: 2025-12-03 (precision: day; source type: ACTUAL; actual)

Primary completion: 2027-08 (precision: month; source type: ESTIMATED; estimated)

Study completion: 2027-08 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.483Z; registry revision: 2026-09-02 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT06989957Psilocybin and Methylenedioxymethamphetamine (MDMA) for Post-traumatic Stress Disorder (PTSD)RecruitingPhase 1United StatesSource start: 2025-09-17 (actual)
Source date details

Start: 2025-09-17 (precision: day; source type: ACTUAL; actual)

Primary completion: 2028-08 (precision: month; source type: ESTIMATED; estimated)

Study completion: 2029-08 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.089Z; registry revision: 2026-09-04 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT05783817MDMA-Assisted CBT for OCD (MDMA-CBT4OCD Study)RecruitingPhase 2United StatesSource start: 2025-09-10 (actual)
Source date details

Start: 2025-09-10 (precision: day; source type: ACTUAL; actual)

Primary completion: 2026-12-01 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2026-12-01 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:16.639Z; registry revision: 2026-03-05 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT06683014MDMA in Borderline Personality DisorderRecruitingPhase 2United StatesSource start: 2025-09-05 (actual)
Source date details

Start: 2025-09-05 (precision: day; source type: ACTUAL; actual)

Primary completion: 2027-06 (precision: month; source type: ESTIMATED; estimated)

Study completion: 2027-06 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:17.720Z; registry revision: 2026-10-22 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT06905652Comparative Acute Effects of R-MDMA and S-MDMA in Healthy ParticipantsCompletedPhase 1SwitzerlandSource start: 2025-07-29 (actual)
Source date details

Start: 2025-07-29 (precision: day; source type: ACTUAL; actual)

Primary completion: 2026-05-12 (precision: day; source type: ACTUAL; actual)

Study completion: 2026-05-12 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:17.780Z; registry revision: 2026-05-15 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT06353282MDMA-Assisted Psychotherapy for Treatment Resistant PTSD in AdolescentsWithdrawnPhase 2United StatesSource start: 2025-07-01 (estimated)
Source date details

Start: 2025-07-01 (precision: day; source type: ESTIMATED; estimated)

Primary completion: 2026-01-31 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2026-12-31 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:17.349Z; registry revision: 2025-04-10 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT06418178Dose Optimization of MDMA-Assisted Therapy for PTSDRecruitingPhase 2United StatesSource start: 2025-06-03 (actual)
Source date details

Start: 2025-06-03 (precision: day; source type: ACTUAL; actual)

Primary completion: 2029-10 (precision: month; source type: ESTIMATED; estimated)

Study completion: 2029-10 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:17.400Z; registry revision: 2026-10-08 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT06954025High-Intensity Inpatient MDMA-Assisted Psychotherapy for PTSDEnrolling by invitationPhase 2NetherlandsSource start: 2025-05-16 (actual)
Source date details

Start: 2025-05-16 (precision: day; source type: ACTUAL; actual)

Primary completion: 2026-12 (precision: month; source type: ESTIMATED; estimated)

Study completion: 2027-01 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.089Z; registry revision: 2025-07-24 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT06884514Acute Effects of MDMA Co-administration on the Response to Psilocybin in Healthy SubjectsCompletedPhase 1SwitzerlandSource start: 2025-04-03 (actual)
Source date details

Start: 2025-04-03 (precision: day; source type: ACTUAL; actual)

Primary completion: 2026-05-13 (precision: day; source type: ACTUAL; actual)

Study completion: 2026-05-28 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:17.780Z; registry revision: 2026-06-25 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT05770375Tolerability of MDMA in SchizophreniaRecruitingPhase 1United StatesSource start: 2024-09-01 (actual)
Saved start 2025-04-01 differs from reported 2024-09-01; the saved day is not established by this observation.
Source date details

Start: 2024-09-01 (precision: day; source type: ACTUAL; actual)

Primary completion: 2027-03-01 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2028-03-01 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:16.639Z; registry revision: 2026-07-17 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

About this data

Compound tags come from automated matching of the registry search term and have not been checked record by record. Counts are of registered studies, not of people, results or approvals.

Other substance hubs

Psilocybin | LSD | DMT | 5-MeO-DMT | Ayahuasca | Ketamine | Ibogaine

Registry status hubs

Recruiting | Not yet recruiting | Active, not recruiting | Enrolling by invitation | Completed | Terminated | Suspended | Withdrawn

Phase hubs

Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Phase not applicable

All trial hubs | Learn | Disclaimer